Literature DB >> 14612212

Interaction between the APOC3 gene promoter polymorphisms, saturated fat intake and plasma lipoproteins.

Sherine Brown1, José M Ordovás, Hannia Campos.   

Abstract

OBJECTIVE: To test the hypothesis that APOC3 gene polymorphisms modulate the effect of saturated fat (SAT) intake on plasma lipoproteins and LDL size.
METHODS: We studied 336 randomly selected residents from Costa Rica. APOC3 polymorphisms were genotyped in the promoter region (T-455C, T-625del) and the C3238G 3' untranslated region (UTR). Dietary intake was assessed by a validated food-frequency questionnaire (FFQ) and median saturated fat intake (11%) was used to define low and high exposure to saturated fat.
RESULTS: Allele frequencies were 0.49, 0.51 and 0.19 for the APOC3-455C, -625de1, and APOC3 3238G alleles, respectively. Significant gene-diet interactions were found for total (P<0.0004) and LDL cholesterol (P<0.01). In homozygotes for the APOC3-455T-625T alleles, saturated fat intake was associated with a 13% increase in total cholesterol (P<0.001) and a 20% increase in LDL cholesterol (P<0.001). In contrast, no association between plasma lipoproteins and saturated fat intake was found among carriers of the APOC3-455C-625del allele. The APOC3 3238G UTR allele did not modify the observed association.
CONCLUSION: Compared to a diet high in saturated fat, a habitually low saturated fat diet is associated with a beneficial lipoprotein profile only among homozygotes of the APOC3 promoter 455T-625T polymorphism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612212     DOI: 10.1016/s0021-9150(03)00293-4

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

1.  APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome.

Authors:  Michael Miller; Jeffrey Rhyne; Hegang Chen; Valerie Beach; Richard Ericson; Kalpana Luthra; Manjari Dwivedi; Anoop Misra
Journal:  Arch Med Res       Date:  2007-03-26       Impact factor: 2.235

Review 2.  Nutrigenomics in cardiovascular medicine.

Authors:  Dolores Corella; Jose M Ordovas
Journal:  Circ Cardiovasc Genet       Date:  2009-12

3.  Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.

Authors:  Andrea S Foulkes; David A Wohl; Ian Frank; Elaine Puleo; Stephanie Restine; Megan L Wolfe; Michael P Dube; Pablo Tebas; Muredach P Reilly
Journal:  PLoS Med       Date:  2006-03       Impact factor: 11.069

4.  Associations of the APOC3 rs5128 polymorphism with plasma APOC3 and lipid levels: a meta-analysis.

Authors:  Yongyan Song; Liren Zhu; Mudwari Richa; Ping Li; Yang Yang; Suping Li
Journal:  Lipids Health Dis       Date:  2015-04-18       Impact factor: 3.876

5.  Sequence analysis and variant identification at the APOC3 gene locus indicates association of rs5218 with BMI in a sample of Kuwaiti's.

Authors:  Zainab H Malalla; Ahmad E Al-Serri; Huda M AlAskar; Wafaa Y Al-Kandari; Suzanne A Al-Bustan
Journal:  Lipids Health Dis       Date:  2019-12-19       Impact factor: 3.876

Review 6.  Genetic Regulatory Networks of Apolipoproteins and Associated Medical Risks.

Authors:  Preethi Basavaraju; Rubadevi Balasubramani; Divya Sri Kathiresan; Ilakkiyapavai Devaraj; Kavipriya Babu; Vasanthakumar Alagarsamy; Vinayaga Moorthi Puthamohan
Journal:  Front Cardiovasc Med       Date:  2022-01-06

7.  SstI Polymorphism of the Apolipoprotein CIII Gene in Iranian Hyperlipidemic Patients: A Study in Semnan Province.

Authors:  Ahmad Reza Bandegi; Mohsen Firoozrai; Mohammad Reza Akbari Eidgahi; Parviz Kokhaei
Journal:  Iran J Basic Med Sci       Date:  2011-11       Impact factor: 2.699

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.